Fauci Declines a Second Senate Panel, Leaving Federal Pandemic Decisions Without Any Completed Public Congressional Review

Also Read

• Boston Scientific Grapples With Global Cyberattack Disrupting Operations
• Dolly Parton Passes Away; Newborns Perish in Pakistan Hospital Blaze; Employers Trim GLP-1 Drug Benefits
• Hormone Replacement Therapy Linked to Reduced Dementia Risk in Large-Scale UK Study
• Next-Generation Therapies for Genetic Cardiovascular Risk Factor Poised for Market Approval